Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2

By Iwasaki Yoshiaki   Tanaka Hironori   Ikeada Hiroshi   Okamoto Ryo-ichi   Araki Yasuyuki   Yabushita Kazuhisa   Kobashi Haruhiko   Kariyama Kazuya   Kawaguchi Mitsuhiko   Takaguchi Kouichi   Sakata Tatsuro   Ando Masaharu   Sakaguchi Kohsaku   Aoki Noriaki   Shiratori Yasushi  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 1, 2011-01 ,pp. : 79-90

Informa Healthcare

Access to resources Recommend Favorite

Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C

By Tohra S.  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2449-2455

Springer Publishing Company

Access to resources Recommend Favorite

High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load

By Tsubota Akihito   Arase Yasuji   Suzuki Fumitaka   Suzuki Yoshiyuki   Akuta Norio   Hosaka Tetsuya   Someya Takashi   Kobayashi Masahiro   Saitoh Satoshi   Ikeda Kenji   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite

Viral Kinetics and Treatment Response in Patients with Hepatitis C During Induction and Standard Interferon Therapy in Combination with Ribavirin

By Carlsson T.   Weiland O.   Reichard O.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 10, 2002-10 ,pp. : 1228-1234

Informa Healthcare

Access to resources Recommend Favorite

Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load

By  

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 426-433

Karger

Access to resources Recommend Favorite